DIPG-42. CAN WE CHANGE THE LANDSCAPE OF PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)? FIRST DEMONSTRATION OF CLINICAL AND RADIOGRAPHIC RESPONSE IN A PEDIATRIC H3-K27M MUTATED DIPG TO THE DRD2-ANTAGONIST ONC201

INTRODUCTION: DIPG is uniformly fatal, with a median survival of 8–9 months. We report the first pediatric patient with H3-K27M mutated DIPG treated with conventional radiotherapy and the small molecule DRD2-antagonist ONC201, with a sustained radiographic and clinical response after 8 months of the...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Neuro Oncol
Główni autorzy: Hall, Matthew, Odia, Yazmin, Allen, Joshua, Tarapore, Rohinton, Khatib, Ziad, Maher, Ossama, Niazi, Toba, Daghistani, Doured, Schalop, Lee, Chi, Andrew, Oster, Wolfgang, Mehta, Minesh
Format: Artigo
Język:Inglês
Wydane: Oxford University Press 2018
Hasła przedmiotowe:
Abstracts
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012972/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.135
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy